Koide T, Ono Y, Ito Y, Akahori M, Nedachi T, Hakuno F, Takenaka A, Takahashi S I, Noguchi T
Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, University of Tokyo, Japan.
Endocr J. 1998 Apr;45(2):151-63. doi: 10.1507/endocrj.45.151.
In FRTL-5 cells, we and others have shown that TSH and insulin-like growth factor-I (IGF-I) stimulate DNA synthesis synergistically. The present study was undertaken to determine whether interaction between TSH and IGF-I also affects protein synthesis in this cell line, and if so by what mechanism. Quiescent cells were treated with TSH and/or IGF-I and [3H]valine incorporation into the acid-insoluble fraction was measured as a parameter of protein synthesis. Similar to their effects on cell proliferation, TSH or IGF-I alone induced protein synthesis only slightly, but treatment with a combination of TSH and IGF-I (or insulin with about a 100-fold higher concentration than IGF-I) greatly increased protein synthesis. The presence of IGF-I potentiated a TSH-concentration-dependent increase in protein synthesis and in DNA synthesis. In addition, we observed this potentiation when the cells were treated with other cAMP-generating agents and cAMP analogues instead of TSH. We have shown that priming with TSH potentiated DNA synthesis induced by IGF-I, whereas pretreatment with IGF-I enhanced protein synthesis induced by TSH. This observation suggested that protein synthesis and DNA synthesis were potentiated through different mechanisms. From an analysis of cAMP production, it appears that the potentiation of protein synthesis may be explained by an IGF-I-dependent increase in cAMP production induced by TSH at least in part. On the other hand, IGF-I and TSH stimulated (alpha-aminoisobutyric acid (AIB) uptake synergistically, but RNA synthesis induced by IGF-I was depressed by TSH. From these results, we concluded that in FRTL-5 cells, IGF-I potentiated protein synthesis induced by TSH by means of complex mechanisms and the interaction between IGF-I and cAMP-dependent pathways may also have a physiological meaning in regulating protein anabolism.
在FRTL-5细胞中,我们和其他研究人员已表明促甲状腺激素(TSH)和胰岛素样生长因子-I(IGF-I)可协同刺激DNA合成。本研究旨在确定TSH与IGF-I之间的相互作用是否也会影响该细胞系中的蛋白质合成,若有影响,则其作用机制是什么。将静止细胞用TSH和/或IGF-I处理,然后测定掺入酸不溶性部分的[3H]缬氨酸量,以此作为蛋白质合成的参数。与它们对细胞增殖的作用相似,单独使用TSH或IGF-I仅轻微诱导蛋白质合成,但用TSH与IGF-I(或浓度比IGF-I高约100倍的胰岛素)联合处理则可大大增加蛋白质合成。IGF-I的存在增强了蛋白质合成和DNA合成中TSH浓度依赖性的增加。此外,当用其他能产生环磷酸腺苷(cAMP)的试剂和cAMP类似物而非TSH处理细胞时,我们也观察到了这种增强作用。我们已表明,用TSH预处理可增强IGF-I诱导的DNA合成,而用IGF-I预处理则可增强TSH诱导的蛋白质合成。这一观察结果表明,蛋白质合成和DNA合成是通过不同机制增强的。从对cAMP产生的分析来看,蛋白质合成的增强至少部分可能是由TSH诱导的IGF-I依赖性cAMP产生增加所解释的。另一方面,IGF-I和TSH协同刺激α-氨基异丁酸(AIB)摄取,但TSH会抑制IGF-I诱导的RNA合成。从这些结果中,我们得出结论,在FRTL-5细胞中,IGF-I通过复杂机制增强TSH诱导的蛋白质合成,并且IGF-I与cAMP依赖性途径之间的相互作用在调节蛋白质合成代谢中可能也具有生理意义。